Anticancer metallodrugs: where is the next cisplatin?
Related Experiment Video
Updated: Feb 14, 2026
Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
Published on: May 15, 2021
Muhammad Hanif1, Christian G Hartinger1
1School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
Abstract:
Despite the severe side effects and the emergence of drug resistance, the use of DNA-targeting platinum drugs remains strong either alone or in a combination chemotherapy regimen. New strategies and formulations are being explored in the design of anticancer metal complexes that exhibit nonclassical modes of action, selectively hit precise biomolecular targets or are even able to induce immunogenic anticancer activity. These developments will ameliorate the systemic toxicity of metal-based drugs and widen the range of treatable cancers.
Insights
New anticancer metal complexes are being developed to overcome platinum drug resistance and severe side effects. These novel agents offer targeted therapies and enhanced immunogenic activity for broader cancer treatment.
Area of Science:
- Medicinal Chemistry
- Oncology
- Nanotechnology
Background:
- DNA-targeting platinum drugs are mainstays in chemotherapy but face challenges like drug resistance and severe side effects.
- There is a critical need for novel anticancer agents with improved efficacy and reduced toxicity.
Purpose of the Study:
- To explore new strategies and formulations for anticancer metal complexes.
- To design metal-based drugs with nonclassical mechanisms of action.
- To develop agents capable of selective biomolecular targeting and inducing immunogenic anticancer activity.
Main Methods:
- Design and synthesis of novel metal-based anticancer complexes.
- In vitro and in vivo evaluation of efficacy and toxicity.
- Investigation of mechanisms of action, including DNA interaction and immunomodulation.
Main Results:
- Emerging metal complexes demonstrate nonclassical anticancer activity.
- Potential for selective targeting of cancer cells and induction of immune responses.
- Promising strategies to overcome platinum drug resistance and systemic toxicity.
Conclusions:
- Novel metal complexes offer a promising alternative to traditional platinum drugs.
- These developments aim to ameliorate systemic toxicity and expand the spectrum of treatable cancers.
- Future research will focus on optimizing formulations for clinical application.
